Evaluation of the quality of life of patients after surgical interventions for complicated forms of colon cancerAuthors: Kubrak M.A. Zavhorodniy S.M. Danylyuk M.B. Т. 13, №4 (52)
Analysis of complications after radical treatment of rectal cancer. VAC therapy as a new method of problem solvingAuthors: Partykevych Y.D. Maliborska S.V. Т. 13, №4 (52)
Past and present in the diagnosis and treatment of T-cell lymphoma: a brief literature review and clinical case reportAuthors: Rudiuk T.O. Tytorenko I.B. Aleksyk O.M. Kalmykova V.V.... Т. 13, № 3 (51)
Modern approaches to the diagnosis and treatment of lymphoproliferative diseases
Xanthine oxidase superoxide radicals as a prognostic factors in colorectal cancer metastatic diseaseAuthors: Burlaka Ant. Virko S. Yefimenko O. Zemskov S.... Т. 13, № 3 (51)
Indications for hematopoietic cell transplantation for lymphoproliferative blood diseases: current practice in Europe, 2022Authors: Tsyapka O.M. Tushnytskyi O.M. Zalokotska L.V. Savuliak H.R.... Т. 13, № 3 (51)
Usage of indocyanine green in routine practice in surgical oncology
Authors: Khoptiana O. Dobrzhanskyi O. Т. 13, № 3 (51)
Authors: Khoptiana O. Dobrzhanskyi O. Т. 13, № 3 (51)
Morphological studies in determining the histogenesis of lung cancerAuthors: Bolhova L.S. Tuganova T.M. Alekseenko O.I. Т. 13, № 3 (51)
Neoadjuvant chemotherapy in resectable locoregionally advanced squamous cell carcinoma of the oral cavity and oropharynxAuthors: Burtyn O.V. Kravets O.V. Hilka O.O. Smolanka I.I.... Т. 13, № 3 (51)
Treatment of patients with recurrent and metastatic forms of breast cancerAuthors: Ivankova V.S. Baranovska L.M. Stoliarova O.Yu. Ivankova O.M.... Т. 13, № 3 (51)
Prospects for the use of pembrolizumab in the treatment of previously untreated patients with advanced malignant pleural mesotheliomaAuthor:Nemish I.L. Т. 13, № 3 (51)
Talazoparib in the treatment of breast cancer. Analysis of the real-world evidence
New stage in personalized breast cancer therapy: a chance for recovery
Modern tactics of treatment of relapsed/refractory multiple myelomaAuthor:Nemish I.L. Т. 13, № 3 (51)
Induction targeted therapy with tyrosine kinase inhibitors in the treatment of EGFR-positive non-small cell lung cancer. Clinical case and discussion of features of therapeutic «targeted» tumor pathomorphosisAuthors: Sukhoversha O.A. Tsyhankov K.V. Kuzhevskyi I.V. Koval S.S. Т. 13, № 2 (50)
